2,031
Views
27
CrossRef citations to date
0
Altmetric
Clinical features - Original research

Ferritin as prognostic marker in COVID-19: the FerVid study

, , , , , , , , , , , , , & ORCID Icon show all
Pages 58-63 | Received 04 May 2021, Accepted 09 Sep 2021, Published online: 17 Oct 2021
 

ABSTRACT

Background

In COVID-19 patients the progressive clinical deterioration seems secondary to the activation of a cytokine storm. Ferritin is considered a direct mediator of the immune system and some evidences suggested a shared physio-pathogenic basis between COVID-19 and ‘Hyperferritinemic Syndromes.’ The aim of our study was to evaluate the prognostic role of ferritin in COVID-19 patients.

Methods

We retrospectively studied consecutive COVID-19 patients admitted to four Italian Internal Medicine Units. Role of potential prognostic markers was evaluated with binary logistic regression analysis and results were expressed as odds ratios (ORs) with the corresponding 95% confidence intervals (CIs). Poor outcome was defined as death or need to transfer in the intensive care unit.

Results

Two hundred patients were included (mean age 68.75 ± 13.22 years). Ferritin value was highly elevated (>3000 ng/mL) in 8% of our population; 13% of patients were transferred to intensive care units and 12% of patients died. At multivariate analysis, highly elevated ferritin levels (OR 16.67 C.I. 4.89–57.57 p < 0.001) and hemoglobin < 10 g/dL (OR 8.88 C.I. 2.02–39.09 p = 0.004) were independently associated with a bad outcome.

Patients with ferritin values > 3000 ng/ml appeared to have an inflammatory activation with elevated values of CRP and D-dimer and low values of lymphocyte count.

Conclusion

Our results confirm the prognostic role of ferritin in hospitalized COVID-19 patients. Patients with high ferritin levels should be considered critically ill and treated in an adequate setting. Furthermore, COVID-19 seems to share some characteristics with hyperferritinemic syndromes with potential therapeutic implications.

Acknowledgements

None reported.

Declaration of financial/other relationships

The authors declare they have no conflict of interest. Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Author contributions

OP conceived of the presented idea. OP and LC developed the theory and performed the computations. FD verified the analytical methods. All authors discussed the results and contributed to the final manuscript.

Additional information

Funding

No funding to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.